Tessera Defense and Homeland Security Inc. (HLSQ) Stock Price

HLSQStock

$0.42

Market Cap—

P/E—

PEG Ratio—

Div yield—

Beta—

HLSQ Share Price Chart

Favorite Metrics

VGM Score2.27

Industry Peers — Biological Products(185)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
HLSQTessera Defense and Homeland Security Inc.	—	—	F	—	—	—	—	$0.42
AMGNAmgen Inc	C	C	A	5.9x	9.1%	74.3%	2.9%	$420.53
GILDGilead Sciences Inc	C	B	B	6.2x	5.5%	79.6%	133.6%	$150.88
MRNAModerna, Inc. Common Stock	F	C	A	35.5x	-27.6%	36.4%	—	$198.64
ARGXargenx SE American Depositary Shares	D	A	B	7.4x	165.2%	89.8%	—	$965.00
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	3759.2x	—	—	—	$202.36
BIIBBiogen Inc. Common Stock	C	D	A	3.4x	0.3%	74.0%	-18.8%	$226.29
BNTXBioNTech SE American Depositary Share	C	C	B	8.2x	-11.8%	79.2%	—	$98.56
EXELExelixis Inc	C	B	B	5.9x	9.2%	96.5%	31.1%	$58.50
NBIXNeurocrine Biosciences Inc	C	B	C	4.2x	34.4%	98.0%	2.3%	$137.85
HALOHalozyme Therapeutics, Inc.	D	B	A	7.7x	41.1%	82.4%	22.9%	$112.07
TWSTTwist Bioscience Corporation Common Stock	D	B	A	27.4x	19.2%	52.0%	—	$184.66
TECHBio-Techne Corp.	D	C	B	9.4x	-0.4%	66.2%	6.0%	$72.42
RGENRepligen Corp	F	C	A	14.0x	16.5%	53.8%	-4.9%	$193.32
APGEApogee Therapeutics, Inc. Common Stock	—	—	A	—	—	—	—	$135.07
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	22.8x	22.6%	94.6%	—	$338.45
IBRXImmunityBio, Inc. Common Stock	F	A	B	56.5x	192.9%	99.3%	—	$8.85
KYMRKymera Therapeutics, Inc. Common Stock	F	B	B	88.7x	134.8%	—	—	$110.99
QGENQIAGEN N.V.	C	C	B	4.4x	3.0%	62.5%	4.2%	$44.42
PCVXVaxcyte, Inc. Common Stock	—	—	B	—	—	—	—	$56.76
IMVTImmunovant, Inc. Common Stock	—	—	B	—	—	—	—	$33.00
IOVAIovance Biotherapeutics, Inc. Common Stock	D	B	A	15.4x	34.5%	48.4%	—	$14.97
CGONCG Oncology, Inc. Common stock	F	A	C	955.7x	1030.3%	-85.2%	—	$69.91
SRRKScholar Rock Holding Corporation Common Stock	F	—	B	128.0x	—	—	—	$47.88
KODKodiak Sciences Inc Common Stock	—	—	B	—	—	—	—	$90.34
CRSPCRISPR Therapeutics AG	D	B	C	395.8x	-64.8%	—	—	$55.42
ADPTAdaptive Biotechnologies Corporation Common Stock	D	B	A	14.6x	50.1%	75.6%	—	$28.95
RLAYRelay Therapeutics, Inc. Common Stock	F	D	B	374.6x	23.9%	—	—	$18.21
TARSTarsus Pharmaceuticals, Inc. Common Stock	D	A	B	5.9x	105.2%	93.3%	—	$76.58
DNLIDenali Therapeutics Inc. Common Stock	F	—	C	931.9x	—	—	—	$20.68
BEAMBeam Therapeutics Inc. Common Stock	D	B	C	16.1x	158.9%	—	—	$24.38
ADMAADMA Biologics, Inc.	C	C	C	4.1x	8.0%	64.7%	—	$10.11
ALVOAlvotech Ordinary Shares	D	D	B	4.5x	-12.1%	60.7%	—	$6.05
BCRXBioCryst Pharmaceuticals Inc	B	A	C	2.3x	68.7%	97.8%	—	$8.29
RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	D	C	C	36.2x	-15.1%	3.5%	—	$3.88
VCELVericel Corporation	D	B	B	6.7x	22.9%	74.6%	38.9%	$40.34
MESOMesoblast Limited American Depositary Shares	D	A	B	16.4x	599.2%	86.1%	—	$14.80
VIRVir Biotechnology, Inc. Common Stock	B	B	B	5.9x	1496.1%	100.0%	—	$10.55
NVAXNovavax Inc	C	D	B	4.2x	-61.6%	79.2%	—	$10.70
IMCRImmunocore Holdings plc American Depositary Shares	D	B	C	3.7x	20.9%	98.9%	—	$30.82
TSHATaysha Gene Therapies, Inc. Common Stock	D	C	C	166.4x	-32.3%	—	—	$4.87
COAGHemab Therapeutics Holdings, Inc. Common Stock	—	—	B	—	—	—	—	$33.58
INBXInhibrx Biosciences, Inc. Common Stock	D	C	B	1047.2x	550.0%	—	—	$104.04
MAZEMaze Therapeutics, Inc. Common Stock	—	A	C	—	700.0%	—	—	$27.20
IMTXImmatics N.V. Ordinary Shares	D	C	C	26.8x	-68.0%	—	—	$8.63
REPLReplimune Group, Inc.	—	—	B	—	—	—	—	$13.30
ODTXOdyssey Therapeutics, Inc. Common Stock	—	C	C	201.4x	-19.0%	—	—	$22.10
MGTXMeiraGTx Holdings plc Ordinary Shares	C	A	C	2.7x	948.4%	98.0%	—	$10.98
SLBTSL Science Holding Limited Ordinary Shares	—	—	F	—	—	—	—	$1.85
GLUEMonte Rosa Therapeutics, Inc. Common Stock	D	F	C	34.8x	-83.9%	—	—	$11.79
VORVor Biopharma Inc. Common Stock	—	—	C	—	—	—	—	$18.20

About Tessera Defense and Homeland Security Inc.

Tessera Defense and Homeland Security Inc develops and acquires technologies that identify, track, and counter physical threats across defense, security, critical infrastructure, and first-response markets - building a portfolio around the growing need for earlier, more accurate threat detection as UAVs and other autonomous systems reshape the operating environment. The Company's portfolio includes Zorronet, an AI-powered autonomous command-and-control platform, and DFSL, a developer of LADAR-based counter-UAS and perimeter security systems.